【摘要】 心脏再同步化治疗(CRT)作为心衰的非药物治疗手段，在符合植入适应证的患者中仍有约30%的无反应率。本文就生物标志物与CRT反应关系研究的进展作一综述，旨在为预测CRT反应提供方向。更多还原

【Abstract】 Cardiac resynchronization therapy(CRT), as a non-drug treatment for heart failure, still has about 30% non-response rate in patients who meet implant indications. The present article makes a review on research progress on relationship between biomarkers and CRT response, aiming at providing direction for predicting CRT response.更多还原